In 1996, Purdue Pharmaceuticals brought to
market OxyContin, an «extended release» version of the opioid oxycodone.
Not exact matches
OxyContin manufacturer's
marketing rollback.
The lawsuit takes primary aim against pharmaceutical companies that make promote,
market and distribute opioid - based drugs such as
OxyContin and Percocet and generics such as oxycodone and hydrocodone.
With the release and aggressive
marketing of the long - acting narcotic
OxyContin in 1996, a class of drugs that had largely been reserved for cancer patients was becoming a go - to treatment for conditions such as lower back pain.
Purdue manufactures
OxyContin and was sued for deceptively
marketing the painkiller.